OSUR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OSUR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-26), OraSure Technologies's current share price is $4.85. OraSure Technologies's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $0.07. OraSure Technologies's Cyclically Adjusted Price-to-FCF for today is 69.29.
The historical rank and industry rank for OraSure Technologies's Cyclically Adjusted Price-to-FCF or its related term are showing as below:
During the past years, OraSure Technologies's highest Cyclically Adjusted Price-to-FCF was 1053.00. The lowest was 42.29. And the median was 167.50.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.
OraSure Technologies's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $0.070. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $0.07 for the trailing ten years ended in Mar. 2024.
The historical data trend for OraSure Technologies's Cyclically Adjusted Price-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OraSure Technologies Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted Price-to-FCF | Get a 7-Day Free Trial | - | - | 394.59 | 190.37 | 87.17 |
For the Medical Instruments & Supplies subindustry, OraSure Technologies's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's Cyclically Adjusted Price-to-FCF distribution charts can be found below:
* The bar in red indicates where OraSure Technologies's Cyclically Adjusted Price-to-FCF falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.
OraSure Technologies's Cyclically Adjusted Price-to-FCF for today is calculated as
Cyclically Adjusted Price-to-FCF | = | Share Price | / | Cyclically Adjusted FCF per Share |
= | 4.85 | / | 0.07 | |
= | 69.29 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OraSure Technologies's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, OraSure Technologies's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:
Adj_FreeCashFlowPerShare | = | Free Cash Flow per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 0.07 | / | 131.7762 | * | 131.7762 | |
= | 0.070 |
Current CPI (Mar. 2024) = 131.7762.
OraSure Technologies Quarterly Data
Free Cash Flow per Share | CPI | Adj_FreeCashFlowPerShare | |
201406 | -0.071 | 100.560 | -0.093 |
201409 | 0.325 | 100.428 | 0.426 |
201412 | -0.027 | 99.070 | -0.036 |
201503 | -0.123 | 99.621 | -0.163 |
201506 | 0.043 | 100.684 | 0.056 |
201509 | 0.314 | 100.392 | 0.412 |
201512 | -0.021 | 99.792 | -0.028 |
201603 | 0.056 | 100.470 | 0.073 |
201606 | 0.193 | 101.688 | 0.250 |
201609 | 0.135 | 101.861 | 0.175 |
201612 | -0.025 | 101.863 | -0.032 |
201703 | 0.200 | 102.862 | 0.256 |
201706 | 0.138 | 103.349 | 0.176 |
201709 | 0.109 | 104.136 | 0.138 |
201712 | -0.049 | 104.011 | -0.062 |
201803 | 0.094 | 105.290 | 0.118 |
201806 | 0.060 | 106.317 | 0.074 |
201809 | 0.151 | 106.507 | 0.187 |
201812 | 0.222 | 105.998 | 0.276 |
201903 | -0.034 | 107.251 | -0.042 |
201906 | 0.020 | 108.070 | 0.024 |
201909 | 0.060 | 108.329 | 0.073 |
201912 | -0.038 | 108.420 | -0.046 |
202003 | -0.038 | 108.902 | -0.046 |
202006 | -0.125 | 108.767 | -0.151 |
202009 | -0.011 | 109.815 | -0.013 |
202012 | -0.165 | 109.897 | -0.198 |
202103 | -0.212 | 111.754 | -0.250 |
202106 | -0.152 | 114.631 | -0.175 |
202109 | -0.329 | 115.734 | -0.375 |
202112 | -0.464 | 117.630 | -0.520 |
202203 | -1.167 | 121.301 | -1.268 |
202206 | -0.283 | 125.017 | -0.298 |
202209 | 0.120 | 125.227 | 0.126 |
202212 | -0.208 | 125.222 | -0.219 |
202303 | 0.028 | 127.348 | 0.029 |
202306 | 0.741 | 128.729 | 0.759 |
202309 | 0.469 | 129.860 | 0.476 |
202312 | 0.535 | 129.419 | 0.545 |
202403 | 0.070 | 131.776 | 0.070 |
Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.
Thank you for viewing the detailed overview of OraSure Technologies's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Kathleen Gallagher Weber | officer: Chief Product Officer | 220 EAST FIRST STREET, BETHLEHEM PA 18017 |
Michele Marie Miller | officer: VP, Finance and Controller | 220 EAST FIRST STREET, BETHLEHEM PA 18017 |
Robert W. Mcmahon | director | 250 CAMPUS DRIVE, MARLBOROUGH MA 01752 |
Kenneth J Mcgrath | officer: Chief Financial Officer | C/O ORASURE TECHNOLOGIES, INC., 220 E. FIRST STREET, BETHLEHEM PA 18015 |
Ronny B Lancaster | director | ORASURE TECHNOLOGIES INC, 220 EAST FIRST STREET, BETHLEHEM PA 18015 |
Mara G. Aspinall | director | 7381 NORTH MOON SPIRIT LANE, TUCSON AZ 85718 |
Nancy J Gagliano | director | 33 GRANITE WAY, GRANTHAM NH 03753 |
Michael Celano | director | 220 EAST FIRST STREET, BETHLEHEM PA 18015 |
Manner Carrie Eglinton | director, officer: President & CEO | C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094 |
Scott Gleason | officer: Interim CFO/SVP IR | 1809 SOUTH 2500 EAST, SALT LAKE CITY UT 84108 |
Eamonn P Hobbs | director | C/O DELCATH SYSTEMS, INC., 600 FIFTH AVENUE, NEW YORK NY 10020 |
Anne Clem Whitaker | director | 109 BRIERY BRANCH COURT, MORRISVILLE NC 27560 |
James A Datin | director | 21 ESTATES DRIVE, DOYLESTOWN PA 18901 |
Lelio Marmora | director | 64 RUE DE VESENEX, DIVONNE LES BAINS I0 01220 |
Lisa Nibauer | officer: President of Diagnostics | 1 CRESENT PLACE, SHORT HILLS NJ 07078 |
From GuruFocus
By GuruFocus Research • 12-22-2023
By Value_Insider Value_Insider • 11-01-2022
By Stock market mentor Stock market mentor • 02-07-2023
By Marketwired • 07-20-2023
By GuruFocusNews GuruFocusNews • 07-04-2022
By GuruFocusNews GuruFocusNews • 07-02-2022
By sperokesalga sperokesalga • 06-13-2023
By GuruFocusNews GuruFocusNews • 06-12-2022
By Marketwired • 10-23-2023
By Marketwired • 08-03-2023